130 related articles for article (PubMed ID: 38104480)
1. Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy: A comparison between two approaches to measuring frailty.
Murugappan MN; King-Kallimanis BL; Bhatnagar V; Kanapuru B; Farley JF; Seifert RD; Stenehjem DD; Chen TY; Horodniceanu EG; Kluetz PG
J Geriatr Oncol; 2024 Mar; 15(2):101681. PubMed ID: 38104480
[TBL] [Abstract][Full Text] [Related]
2. Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study.
Efficace F; Gaidano G; Petrucci MT; Niscola P; Cottone F; Codeluppi K; Antonioli E; Tafuri A; Larocca A; Potenza L; Fozza C; Pastore D; Rigolin GM; Offidani M; Romano A; Kyriakou C; Cascavilla N; Gozzetti A; Derudas D; Vignetti M; Cavo M
Lancet Healthy Longev; 2022 Sep; 3(9):e628-e635. PubMed ID: 36102777
[TBL] [Abstract][Full Text] [Related]
3. Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma.
Murugappan MN; King-Kallimanis BL; Bhatnagar V; Kanapuru B; Farley JF; Seifert RD; Stenehjem DD; Chen TY; Horodniceanu EG; Kluetz PG
Qual Life Res; 2023 Aug; 32(8):2281-2292. PubMed ID: 36935467
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
Djebbari F; Rampotas A; Panitsas F; Lim WY; Lees C; Tsagkaraki I; Gomes AR; Prideaux S; Chen L; Prodger C; Khera A; Gray N; Ellis L; Sangha G; Eyre TA; Moore S; Kothari J; Ramasamy K
PLoS One; 2022; 17(1):e0262388. PubMed ID: 35015781
[TBL] [Abstract][Full Text] [Related]
5. Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older.
Murillo A; Cronin AM; Laubach JP; Hshieh TT; Tanasijevic AM; Richardson PG; Driver JA; Abel GA
J Geriatr Oncol; 2019 May; 10(3):486-489. PubMed ID: 30472368
[TBL] [Abstract][Full Text] [Related]
6. A comparison of three different approaches to defining frailty in older patients with multiple myeloma.
Isaacs A; Fiala M; Tuchman S; Wildes TM
J Geriatr Oncol; 2020 Mar; 11(2):311-315. PubMed ID: 31326393
[TBL] [Abstract][Full Text] [Related]
7. Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.
Engelhardt M; Dold SM; Ihorst G; Zober A; Möller M; Reinhardt H; Hieke S; Schumacher M; Wäsch R
Haematologica; 2016 Sep; 101(9):1110-9. PubMed ID: 27479825
[TBL] [Abstract][Full Text] [Related]
8. Frailty in Older Adults With Multiple Myeloma: A Study of US Veterans.
Patel BG; Luo S; Wildes TM; Sanfilippo KM
JCO Clin Cancer Inform; 2020 Feb; 4():117-127. PubMed ID: 32083955
[TBL] [Abstract][Full Text] [Related]
9. Accessing the discriminatory performance of FRAIL-NH in two-class and three-class frailty and examining its agreement with the frailty index among nursing home residents in mainland China.
Ge F; Liu W; Liu M; Tang S; Lu Y; Hou T
BMC Geriatr; 2019 Oct; 19(1):296. PubMed ID: 31666011
[TBL] [Abstract][Full Text] [Related]
10. Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study.
Zhang Y; Liang X; Xu W; Yi X; Hu R; Ma X; Yan Y; Zhang N; Wang J; Sun X; Zhu Y; Tian M; Lan M; Long M; Dai Y; Jin F
J Hematol Oncol; 2024 Jun; 17(1):48. PubMed ID: 38915117
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review.
Mian H; McCurdy A; Giri S; Grant S; Rochwerg B; Winks E; Rosko AE; Engelhardt M; Pawlyn C; Cook G; Jackson G; Bringhen S; Facon T; Larocca A; Zweegman S; Wildes TM
Blood Cancer J; 2023 Jan; 13(1):6. PubMed ID: 36599867
[TBL] [Abstract][Full Text] [Related]
12. Elderly patients with multiple myeloma: towards a frailty approach?
Zweegman S; Engelhardt M; Larocca A;
Curr Opin Oncol; 2017 Sep; 29(5):315-321. PubMed ID: 28763310
[TBL] [Abstract][Full Text] [Related]
13. The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia.
Sim S; Kalff A; Tuch G; Mollee P; Ho PJ; Harrison S; Gibbs S; Prince HM; Spencer A; Joshua D; Lee C; Ling S; Murphy N; Szabo F; Szer J; Weber N; Ward C; Talaulikar D; Zannettino A; Quach H
Intern Med J; 2023 May; 53(5):819-824. PubMed ID: 36880355
[TBL] [Abstract][Full Text] [Related]
14. Transplant eligibility in elderly multiple myeloma patients: Prospective external validation of the international myeloma working group frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65-75 years.
Belotti A; Ribolla R; Cancelli V; Crippa C; Bianchetti N; Ferrari S; Bottelli C; Cattaneo C; Tucci A; De La Fuente Barrigon C; Rossi G
Am J Hematol; 2020 Jul; 95(7):759-765. PubMed ID: 32242970
[TBL] [Abstract][Full Text] [Related]
15. Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population.
Lee HS; Lee J; Jo JC; Jung SH; Lee JJ; Kim D; Lee S; Song K
Sci Rep; 2021 Nov; 11(1):22907. PubMed ID: 34824362
[TBL] [Abstract][Full Text] [Related]
16. Electronic FRAIL score may predict treatment outcomes in older adults with myeloma.
Chan H; Chong YH; Seow MY; Li J; Garg P; Kelly M; Neylon A; McDiarmid B; Tan S; Jackson S
J Geriatr Oncol; 2021 May; 12(4):515-520. PubMed ID: 33046409
[TBL] [Abstract][Full Text] [Related]
17. A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol.
Efficace F; Boccadoro M; Palumbo A; Petrucci MT; Cottone F; Cannella L; Zamagni E; Niscola P; Kyriakou C; Caravita T; Offidani M; Mandelli F; Cavo M
Health Qual Life Outcomes; 2018 Jun; 16(1):127. PubMed ID: 29914509
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study.
Yao Y; Sui WW; Liao AJ; Wang W; Chen LJ; Chu XX; Bao L; Cen XN; Fu R; Liu H; Sun CY; Jin FY; Yan H; Wang LQ; Yuan CL; Gao GX; Gao D; Zhang JQ; He JX; Hu JD; Ma LM; Zhang L; Zhou DB; Zou DH; Li J
Age Ageing; 2022 Jan; 51(1):. PubMed ID: 34673897
[TBL] [Abstract][Full Text] [Related]
19. A 10-Item Frailty Index Based on a Comprehensive Geriatric Assessment (FI-CGA-10) in Older Adults with Cancer: Development and Construct Validation.
Nishijima TF; Shimokawa M; Esaki T; Morita M; Toh Y; Muss HB
Oncologist; 2021 Oct; 26(10):e1751-e1760. PubMed ID: 34216413
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty score.
Chen Y; Gu J; Huang B; Liu J; Li X; Li J
Front Oncol; 2023; 13():1103687. PubMed ID: 36741003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
